Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Shokeen

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Seminars in Radiation Oncology|November 28, 2020
Novel Agents and Future Perspectives on TheranosticsLilja B Solnes, Monica Shokeen, Neeta Pandit-Taskar
Nuclear Medicine and Biology|December 26, 2012
Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumorsMajiong Jiang, Riccardo Ferdani, Monica Shokeen, et al.
Nuclear Medicine and Biology|February 10, 2024
Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastasesMichael R Dyer, Zhenghan Jing, Kathleen Duncan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2018
Imaging Melphalan Therapy Response in Preclinical Extramedullary Multiple Myeloma with <sup>18</sup>F-FDOPA and <sup>18</sup>F-FDG PETDeep K Hathi, Elizabeth N DeLassus, Samuel Achilefu, et al.
Journal of Biomedical Optics|September 1, 2016
Enhancing in vivo tumor boundary delineation with structured illumination fluorescence molecular imaging and spatial gradient mappingJessica Sun, Jessica P Miller, Deep Hathi, et al.
NMR in Biomedicine|June 18, 2019
Longitudinal preclinical magnetic resonance imaging of diffuse tumor burden in intramedullary myeloma following bortezomib therapyDeep K Hathi, John A Engelbach, Jens Hillengass, et al.
Scientific Reports|July 26, 2022
Activation of nano-photosensitizers by Y-90 microspheres to enhance oxidative stress and cell death in hepatocellular carcinomaChristopher D Malone, Christopher Egbulefu, Alexander Zheleznyak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2020
Development of [<sup>89</sup>Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myelomaAnchal Ghai, Alexander Zheleznyak, Matt Mixdorf, et al.
Research Square|June 5, 2025
Advanced Quantification Pipeline Reveals New Spatial and Temporal Tumor Characteristics in Preclinical Multiple MyelomaZhixin Sun, Jacqueline Godbe, Alexander Zheleznyak, et al.
EJNMMI Research|September 29, 2021
In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [<sup>18</sup>F]FDG and [<sup>64</sup>Cu]Cu-LLP2A PETAnchal Ghai, Nikki Fettig, Francesca Fontana, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Seminars in Radiation Oncology|November 28, 2020
Novel Agents and Future Perspectives on TheranosticsLilja B Solnes, Monica Shokeen, Neeta Pandit-Taskar
Nuclear Medicine and Biology|December 26, 2012
Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumorsMajiong Jiang, Riccardo Ferdani, Monica Shokeen, et al.
Nuclear Medicine and Biology|February 10, 2024
Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastasesMichael R Dyer, Zhenghan Jing, Kathleen Duncan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2018
Imaging Melphalan Therapy Response in Preclinical Extramedullary Multiple Myeloma with <sup>18</sup>F-FDOPA and <sup>18</sup>F-FDG PETDeep K Hathi, Elizabeth N DeLassus, Samuel Achilefu, et al.
Journal of Biomedical Optics|September 1, 2016
Enhancing in vivo tumor boundary delineation with structured illumination fluorescence molecular imaging and spatial gradient mappingJessica Sun, Jessica P Miller, Deep Hathi, et al.
NMR in Biomedicine|June 18, 2019
Longitudinal preclinical magnetic resonance imaging of diffuse tumor burden in intramedullary myeloma following bortezomib therapyDeep K Hathi, John A Engelbach, Jens Hillengass, et al.
Scientific Reports|July 26, 2022
Activation of nano-photosensitizers by Y-90 microspheres to enhance oxidative stress and cell death in hepatocellular carcinomaChristopher D Malone, Christopher Egbulefu, Alexander Zheleznyak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2020
Development of [<sup>89</sup>Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myelomaAnchal Ghai, Alexander Zheleznyak, Matt Mixdorf, et al.
Research Square|June 5, 2025
Advanced Quantification Pipeline Reveals New Spatial and Temporal Tumor Characteristics in Preclinical Multiple MyelomaZhixin Sun, Jacqueline Godbe, Alexander Zheleznyak, et al.
EJNMMI Research|September 29, 2021
In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [<sup>18</sup>F]FDG and [<sup>64</sup>Cu]Cu-LLP2A PETAnchal Ghai, Nikki Fettig, Francesca Fontana, et al.
Pageof 5